- Home
- INO vs AXR Comparison
INO vs AXR Comparison
Compare INO & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INO | AXR |
|---|---|---|
| Founded | 1979 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Homebuilding |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.6M | 127.3M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | AXR |
|---|---|---|
| Price | $1.75 | $19.25 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 9.5K |
| Earning Date | 11-10-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.95 |
| Revenue | $182,337.00 | ★ $45,947,000.00 |
| Revenue This Year | N/A | $28.57 |
| Revenue Next Year | $21,214.02 | N/A |
| P/E Ratio | ★ N/A | $9.68 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.30 | $17.60 |
| 52 Week High | $2.98 | $34.00 |
Technical Indicators
Market Signals| Indicator | INO | AXR |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | 39.87 |
| Support Level | $2.11 | $18.75 |
| Resistance Level | $2.37 | $19.07 |
| Average True Range (ATR) | 0.19 | 0.91 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 6.16 | 40.43 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About AXR AMREP Corporation
Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.